Search clinical trials for: nalbuphine plus naloxone

Total 5170 results

University of California, San Francisco

Terminated

Effect of Nalbuphine and Naloxone on Experimentally Induced Skin Sensitivity

Healthy

United States
University of California, San Francisco

Terminated

Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain

Temporomandibular Joint Dysfunction Syndrome | Burning Mouth Syndrome

United States
Lumosa Therapeutics Co., Ltd.

Completed

A Bioavailability Study of NALDEBAIN ER Injection and Nalbuphine Injection in Healthy Volunteers.

Health

United States
Lumosa Therapeutics Co., Ltd.

Completed

A Bioavailability Study of Sebacoyl Dinalbuphine Ester IM Injection in Healthy Volunteers

Pain | Analgesia Disorder

Taiwan
Lumosa Therapeutics Co., Ltd.

Completed

A Study of Intramuscular Sebacoyl Dinalbuphine Ester for Post-Hemorrhoidectomy Pain Management

Pain | Analgesia Disorder

Taiwan
Assiut University

Completed

Effect of Caudal Nalbuphine on Postoperative Analgesia in Children

Postoperative Pain

Egypt
Samjin Pharmaceutical Co., Ltd.

Completed

A Phase 4 Clinical Study to Investigate the Efficacy and Safety of Naloxone HCI IV in Patients With Stroke

Stroke, Acute

Korea, Republic of
Abdelrady S Ibrahim, MD

Completed

The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section

Postoperative Pain

Egypt
Trevi Therapeutics

Completed

Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis

Prurigo Nodularis | Prurigo | Nodularis Prurigo

Germany
Trevi Therapeutics
Syneos Health

Unknown

Nalbuphine ER Effects of Liver Disease on Pharmacokinetics and Itch

Hepatic Impairment | Nalbuphine

United States
Mansoura University

Completed

Effect of Ultra-low Dose Naloxone During Supraclavicular Brachial Plexus Block on Post-operative Opioi

Upper Extremity Trauma

Egypt
Trevi Therapeutics

Completed

Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus

Pruritus | Uremic Pruritus

United States
Trevi Therapeutics

Recruiting

Cough Reduction in IPF With Nalbuphine ER (CORAL)

Idiopathic Pulmonary Fibrosis

United Kingdom, Australia, Netherlands, Italy, Spain, Poland, Turkey, Canada, Chile, Germany
Trevi Therapeutics

Completed

Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Pruritus | Uremic Pruritus

United States, Poland, Romania
Assiut University

Completed

Systemic Nalbuphine Versus Intravenous Regional Anesthesia

Postoperative Pain

Egypt
Judith Feinberg

Unknown

Nasal Naloxone for Narcotic Overdose

Drug Overdose

United States
Minia University

Unknown

Adding Nalbuphine for Control of Intrathecal Morphine Pruritus

Pain, Postoperative | Pruritus | Nausea, Postoperative | Vomiting, Postoperative

Egypt
Trevi Therapeutics

Completed

Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis

Pruritus | Prurigo Nodularis | Prurigo | Nodularis Prurigo

United States, Germany, Poland
Xijing Hospital

Completed

Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal Surgery

Gastrointestinal Surgery

China
Tri-Service General Hospital

Unknown

The Development of Oral Nalbuphine Dosage Form (NAL)

Healthy

Taiwan
mads u werner
University of Kentucky

Completed

Effect of High-dose Target-controlled Naloxone Infusion on Pain and Hyperalgesia During a Burn Injury (TCI-NX-BI)

Healthy Subjects

Denmark
S.L.A. Pharma AG

Completed

Naloxone SR Capsules in Patients With Opioid Induced Constipation

Chronic Pain | Opioid Induced Constipation

Germany, United Kingdom
Pocket Naloxone Corp

Completed

Pharmacokinetic Evaluation of a New Naloxone Nasal Swab, Naloxone Nasal Spray, and Intramuscular Naloxone Injection in Healthy Volunteers

Opioid Overdose

Canada
mads u werner
University of Kentucky

Completed

Effect of High-dose Naloxone Following Third Molar Extraction (TME)

Pain, Acute | Healthy Subjects | Hyperalgesia | Sensitization, Central | Inflammations, Endodontic

Denmark
Norwegian University of Science and Technology
St. Olavs Hospital; Smerud Medical Research International AS; A/S Den norske...

Completed

Bioavailability of Nasal Naloxone and Injected Naloxone Compared (OPI-15-002)

Drug Overdose

Norway
Trevi Therapeutics
Davita Clinical Research

Completed

Phase 1 Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus

Uremic Pruritus
INSYS Therapeutics Inc

Completed

A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers

Healthy Volunteer

United States
Leiden University Medical Center
U.S. Food and Drug Administration (FDA)

Recruiting

Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists (ROAR)

Chronic Opioid Use | Opioid Induced Respiratory Depression

Netherlands
INSYS Therapeutics Inc

Completed

A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers

Healthy Volunteer

United States
Norwegian University of Science and Technology
St. Olavs Hospital

Completed

Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use (OPI-14-001)

Drug Overdose

Norway
Assiut University

Completed

Effect of Intravenous Nalbuphine on Emergence Agitation

Postoperative Complications

Egypt
National Taiwan University Hospital

Unknown

Interaction Between Nalbuphine and Morphine in PCA

Postoperative Pain

Taiwan
Norwegian University of Science and Technology
St. Olavs Hospital; University of Iceland

Completed

A Pilot Study of the Bioavailability of Nasal Naloxone

Drug Overdose

Norway
University of Washington

Unknown

Subjective Analgesic Effects of Naloxone and Virtual Reality (Narcan)

Pain

United States
Duke University
National Institute on Drug Abuse (NIDA); The Emmes Company, LLC

Completed

Buprenorphine Physician-Pharmacist Collaboration in the Management of Patients With Opioid Use Disorder: CTN 0075 (Pharm-OUD-Care)

Opioid Use Disorder

United States
Parc de Salut Mar
Food and Drug Administration (FDA)

Recruiting

Pharmacokinetics of Intravenous and Intranasal Formulations of Naloxone in Healthy Volunteers.

Healthy

Spain
University of Minnesota

Completed

Naloxone, Hypoglycemia and Exercise

Diabetes Mellitus, Type 1

United States
Finnish Institute for Health and Welfare

Completed

Treatment of Gambling Disorder With Fast Acting Opiate Antagonist, Naloxone Nasal Spray (NALPILO)

Naloxone | Gambling | Spray | Opioid

Finland
Kaiser Permanente
National Institute on Drug Abuse (NIDA); Denver Health and Hospital Authority

Completed

Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders

Risk Behavior | Opioid Abuse | Overdose

United States
Norwegian University of Science and Technology
Oslo University Hospital; St. Olavs Hospital

Completed

Naloxone Nasal Spray Compared With Naloxone Injection for Opioid Overdoses Outside the Hospital (NINA-1)

Overdose | Drug Abuse

Norway
Trevi Therapeutics

Recruiting

Refractory Chronic Cough Improvement Via NAL ER (RIVER) (RIVER)

Refractory Chronic Cough

Canada, United Kingdom
Chun Pan
Southeast University, China

Unknown

The Effect of Analgesic Drugs on Respiratory Center

The Effect of Analgesic Drugs on Respiratory Center

China
Emergent BioSolutions

Completed

Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults

Opioid Overdose

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence

Opiate Dependence

United States
Kaohsiung Medical University Chung-Ho Memorial...

Completed

Naldebain for Pain Management After Knee Arthroplasty

Arthropathy of Knee Joint

Taiwan
State University of New York - Upstate Medical...
Binghamton University

Completed

A Usability Assessment of Naloxone Administration by Untrained Community Members

Harm Reduction | Opioid-use Disorder | Naloxone

United States
Chulalongkorn University

Not yet recruiting

Effectiveness of Intrathecal Nalbuphine as an Adjuvant to Subarachnoid Block on Postoperative Analgesia in Patients Undergoing Transurethral Resection of the Prostate

Transurethral Resection of Prostate

Thailand
INSYS Therapeutics Inc

Completed

Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers

Opiate Dependence

United States
Bicycle Health

Enrolling by invitation

Novel Induction to Buprenorphine/Naloxone

Opioid Use Disorder | Opioid Dependence | Opioid Use | Opioid Abuse | Opioid Misuse

United States
National Institute on Drug Abuse (NIDA)
Johns Hopkins University

Terminated

Abuse Potential of Buprenorphine/Naloxone

Opioid-Related Disorders

United States

Search clinical trials for: nalbuphine plus naloxone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Brazil

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations